Style de citation APA (7e éd.)

Kuo, C., Chen, C., Li, C., Huang, G., Ma, W., Hsu, W., . . . Wo, A. M. (2019). Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models. Nature Portfolio.

Style de citation Chicago (17e éd.)

Kuo, Chun-Ting, Chen-Lin Chen, Chih-Chi Li, Guan-Syuan Huang, Wei-Yuan Ma, Wei-Fan Hsu, Ching-Hung Lin, Yen-Shen Lu, et Andrew M. Wo. Immunofluorescence Can Assess the Efficacy of MTOR Pathway Therapeutic Agent Everolimus in Breast Cancer Models. Nature Portfolio, 2019.

Style de citation MLA (8e éd.)

Kuo, Chun-Ting, et al. Immunofluorescence Can Assess the Efficacy of MTOR Pathway Therapeutic Agent Everolimus in Breast Cancer Models. Nature Portfolio, 2019.